La Financiere de L'Echiquier Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$18M |
| 2 |
Enphase Energy
ENPH
|
+$12M |
| 3 |
Danaher
DHR
|
+$11.3M |
| 4 |
Accenture
ACN
|
+$11.3M |
| 5 |
Broadcom
AVGO
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$86.4M |
| 2 |
Microsoft
MSFT
|
+$38.8M |
| 3 |
Keurig Dr Pepper
KDP
|
+$34.2M |
| 4 |
Edwards Lifesciences
EW
|
+$19.1M |
| 5 |
Visa
V
|
+$8.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.04% |
| 2 | Financials | 17.46% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Healthcare | 9.33% |
| 5 | Communication Services | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Edwards Lifesciences
EW
$53.5B
| – | – |
-230,874
| Closed | -$19.1M |
|
102
Johnson & Johnson
JNJ
$626B
| – | – |
-2,850
| Closed | -$442K |
|
103
SolarEdge
SEDG
$2.01B
| – | – |
-21,041
| Closed | -$6.4M |
|
Similar funds
La Financiere de L'Echiquier's Q2 2023 Portfolio in Review
As of Q2 2023, La Financiere de L'Echiquier held 103 positions worth $2B, up 4.9% from $1.91B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
La Financiere de L'Echiquier withdrew a net $114M in Q2 2023, closing 5 positions and reducing 42 holdings. Its most notable exit was Edwards Lifesciences, an estimated $19.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, La Financiere de L'Echiquier opened a new position in Enphase Energy worth $11.2M.
- La Financiere de L'Echiquier's largest Q2 2023 buy was Enphase Energy: 67,000 shares worth $11.2M.
- La Financiere de L'Echiquier added most to TSMC in Q2 2023, an estimated $18M increase.
- La Financiere de L'Echiquier's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $86.4M.
- La Financiere de L'Echiquier fully exited Edwards Lifesciences in Q2 2023, selling an estimated $19.1M.
- La Financiere de L'Echiquier's ten largest holdings make up 51% of its $2B portfolio in Q2 2023.
- La Financiere de L'Echiquier opened 8 new positions and closed 5 in Q2 2023.
- La Financiere de L'Echiquier's portfolio value rose 4.9% quarter-over-quarter to $2B.
Based on La Financiere de L'Echiquier's 13F filing for Q2 2023, filed 10 Aug 2023.